| Literature DB >> 34044844 |
Abstract
BACKGROUND: Human airway epithelial (HAE) cellular models are widely used in applicative studies of the airway physiology and disease. In vitro expanded and differentiated primary HAE cells collected from patients seem to be an accurate model of human airway, offering a quicker and cheaper alternative to the induced pluripotent stem cell (iPSCs) models. However, the biggest drawback of primary HAE models is their limited proliferative lifespan in culture. Much work has been devoted to understand the factors, which govern the HAE cell proliferation and differentiation, both in vivo and in vitro. Here, I have summarized recent achievements in primary HAE culture, with the special emphasis on the models of conditionally reprogrammed cells (CRC), which allow longer in vitro proliferation and differentiation of HAE cells. The review compares the CRC HAE technique variants (feeder culture or HAE mono-culture), based on recently published studies exploiting this model. The advantages and limitations of each CRC HAE model variant are summarized, along with the description of other factors affecting the CRC HAE culture success (tissue type, sampling method, sample quality).Entities:
Keywords: Air–liquid interface culture; Conditional reprogramming; Primary airway cell culture; ROCK inhibitor; SMAD inhibitor; TGF-β1 inhibitor
Mesh:
Year: 2021 PMID: 34044844 PMCID: PMC8159066 DOI: 10.1186/s12964-021-00740-z
Source DB: PubMed Journal: Cell Commun Signal ISSN: 1478-811X Impact factor: 5.712
Fig. 1Airway epithelial differentiation pathways. a Differentiation of airway epithelial cells during embryonic development. b Differentiation of airway epithelial cells after birth (from adult stem cells). Names below the different cell types are the markers of the specific cell types (based on recent human single-cell RNAseq studies [21, 24]). TP63, KRT5, KRT6C, KRT14 and KRT15 are basal cell markers, while supra-basal cells are characterized by expression of KRT4, KRT13, KRT16 and KRT23. Within the mucociliary lineage, club cells are distinguished by expression of Scgb1a1, KRT7 and KRT19, mature goblet cells have expression of SPDEF, FOXQ1 and MUC5AC. The deuterosomal cells express PLK4, CCNO, CEP78 and DEUP1, while mature ciliated cells are distinguished by the expression of DNAH5, SPEF2, PIFO and LRRC6. Suprabasal cells can give rise to tuft cells, which express POUF2F3 and TRPM5. These in turn can differentiate either to ionocytes, expressing FOXI1 or CFTR, or to neuroendocrine cells, expressing PSMD5 or NGF
Fig. 2Existing culturing platforms for HAE expansion and differentiation. ALI – air–liquid interface culture; BC- basal cell
Recent studies exploiting CRC HAE co-culture method with feeder cells
| CRC HAE culture with feeder cells | |||||||
|---|---|---|---|---|---|---|---|
| Publication | Cell type, sample type, age group | Feeder cells? /Cell stasis factor | Expansion | Differentiation | Culture length: | Major findings: | Limitations |
| Suprynowicz [ | HTE epithelium | Yes, IR | Submerged culture, KSFM or F-medium, 10uM Y27632; Vessels: no coating | ALI culture, Until confluence- CELLnTEC CnT57 medium + 10 μM Y-27632 Later: CELLnTEC CnT-02–3D differentiation medium, 14 days | Passage number N/A, forms cilia in ALI | 1. Stable karyotype, non-tumorigenic 2. Rapid and reversible induction of cell divisions 3. Maintenance of lineage characteristics | Unknown maximal number of passages for HAE culture |
| Butler [ | Yes, IR or mitomycin C | Submerged culture: DMEM- F12 (3:1 ratio), 5% FBS, 5 uM Y-27632, hydrocortisone (25 ng/ml), epidermal growth factor (0.125 ng/ml) insulin (5 mg/ml), 0.1 nM cholera toxin, amphotericin B (250 mg/ml) and gentamicin (10 mg/ml), pen-strep (1x) Vessels: no coating | Differentiation: suspension culture (tracheospheres) or ALI | Expansion for > 3 months (split ratio 1:5), cells expanded for > 6 weeks can differentiate (tracheospheres, ALI) | 1. CRC cells are non-tumorigenic and react to contact inhibition 2. Cell yield sufficient for tissue engineering/ regeneration (> 1 × 107 cells obtained in < 4 weeks) | n/a | |
| Reynolds [ | Yes, IR | Submerged culture: DMEM:F12 (3:1) + 7,3% FBS, hydrocortisone/EGF mix, Cholera toxin 8,6 ng/ul, Adenine 24 ng/ul, Insulin 10ug/ml Vessel coating: rat tail collagen type I (30 µg/ml) Conditions compared with regular BEGM culture | ALI culture, organotypic raft cultures or 3D tracheospheres in Matrigel | CRC expanded HNE cells could be differentiated at P4, in contrast to BEGM-expanded HNE cells. | 1. Increased clone formation 2. Increased cell yield compared to BEGM (~ 400 fold) 3. Mechanism of Y-27632 action: (a) promotion of the basal cell phenotype; (b) stimulation of basal cell–specific cell–cell and cell–ECM interactions; and (c) suppression of differentiation to an airway luminal cell phenotype | 1) For some donors—almost no MCC visible (MCC number: from < 10% to ~ 40%); 2) Limitated proliferative lifespan of HNEs expanded in CRC or BEGM, visible already after 2 passages (less pronounced in CRCs) | |
| Wolf [ | conditioned medium from IR fibroblasts | Submerged culture: BEGM medium conditioned by 72 h incubation with NIH-3T3 fibroblasts irradiated with 30 Gy and frozen in aliquots. Conditioned BEGM mixed with fresh BEGM (3:1 v/v); supplemented with 10 µM Y-27632 Vessels coating: human placental collagen type IV | ALI culture; Conditioned BEGM medium + Y-27632 to the basolateral compartment only | ~ 13–14 PDs within 30 days (split ratio 1:4) | 1. Increased proliferation and extended proliferative lifespan 2. Maintenance of lineage characteristics after multiple passages, 3. Physiological airway responses to dsRNA (induction of antiviral genes, IFN λ1 production, inflammatory and remodeling responses) | 1) Weak differentiation at ALI for some donors; 2) Not sure whether the anti-viral responses observed in CRCs are identical to the in vivo HAE responses (CRCs induction changes expression of some inflammatory genes) | |
| Brewington [ | HNE samples from healthy or CF patients (curettage, from newborns to adults) | YES, IR (commercially available, frozen) | Submerged culture: DMEM/F12 + 10% FBS, cholera toxin (0,01 mg), EGF (0,04ug), HC (0,4ug/500 ml), Adenine (24 mg), Y-27632 (3,2 mg) + antibiotics Vessel coating: VitroCOl | Suspension culture (spheroids): DMEM/F12 + Ultroser G, 20 ml Fetal Clone II, Bovine Brain Extract, Transferrin, epinephrine, ethanolamine, insulin, HC, RA, triiodothyronine, phosphorylethanolamine | spheroids differentiate within 10 days | 1. Faster differentiation of spheroids than ALI cultures 2. Spheroid swelling is a quick and robust assay for CFTR activity | 1) Short availability of spheroids for analysis 2) No information on the differentiation capacity beyond passage 2 3) Preclinical utility not fully clear (drug testing in CF patients?) |
| Peters- Hall [ | YES, IR | Submerged culture: P0-P3: BEGM, 0.5 ng/ml EGF, 2% O2 P3 -5: (CRC culture); BEGM, 5% FBS, 10uM Y-27632, no coating, 2% O2 Vessel coating: P0-P3: Porcine gelatin, P3-P5: no coating | ALI culture, P5 + (Transwells, expansion): BEGM + 10uM Y-27632, no coating, 21% O2 P5 + (ALI): BEGM, 0.5 ng/ml EGF, 0.11 mM CaCl2, 0.1 mg/ml BPE, 21% O2 | up to 47 PDs (passage 15) | 1. Increased ciliation of MOD CRCs at P5 and P10 (~ 33–38%) 2. CFTR activity probably retained at later passages 3. Increased HBECs lifespan allowed CRISPR-Cas9 gene edition 4. Mod CRC conditions reduce cellular stress in HBECs from non-CF donors and prevent premature cellular senescence | Requires various media, complicated procedure | |
Fig. 3Mechanisms of conditional HAE reprogramming allowing proliferation of basal cells. ROCKi – ROCK inhibitor, PAK1i – PAK1 inhibitor, Myosin IIi- inhibitor of Myosin II, SMADi – inhibitor of SMAD, mTORi – inhibitor of mTOR pathway
Recent studies exploiting feeder-free methods of CRC HAE culture
| Feeder-free CRC HAE culture | ||||||||
|---|---|---|---|---|---|---|---|---|
| Publication: | Feeder cells? | Expansion: | Differentiation: | Culture length: | Major findings: | Limitations | ||
| ONLY ROCKi | Horani [ | NO | Submerged culture: DMEM/F-12 with 15 mM HEPES, 4 mM L-Glutamine, 3.6 mM NaHCO3, 100 U/mL penicillin, and 100 mg/mL streptomycin with supplements (10 mg/mL insulin, 5 mg/mL transferrin, 0.1 mg/mL cholera toxin, 25 ng/mL EGF, 30 mg/mL BPE, 5% FBS (v/v)) Vessel coating: rat tail collagen type I (50 mg/ml) | In ALI, mTEC/Basic Medium with 2% NuSerum and retinoic acid [ | Highest proliferation at 5 µM Y27632. ~ 25% cilia in hTEC | 1. Y27632 increased cell proliferation, efficiency of lentiviral transduction (up to 80%), and facilitated antibiotic selection of transduced cells | Decreased number of goblet cells during ALI (0–19 Muc5AC + cells/ 100-power visual field) | |
| Jonsdottir [ | NO | Submerged culture: BEGM medium with 10uM Y-27632 Vessel coating: Collagen Type IV | ALI, LHC:DMEM medium + supplements [ Vessel coating: Collagen Type IV | Cells used until P4 | 1. Lentiviral suspension transduction method established (15 -70% efficiency, depending on the virus titer) 2. Addition of ROCKi slightly decreased this efficiency (5%–10% lower), but allowed selection of cells after transduction | Not all constructs were equally effective—careful evaluation and testing of the viral constructs is required | ||
| OTHER SUPPLEMENTS/ INHIBITORS | Mou et al. [ | fresh human | NO | Submerged culture: Different media (with/without 5–10 mM ROCKi, 0.5–1 mM A-83–01, 0.5–1 mM DMH-1, and 1 mM CHIR99021, separately or in various combinations). Media tested: SAGM (Lonza), HTEC (You and Brody, 2013), BEGM (Fulcher et al. 2005), LHC (Life Technologies), LHC-9 (Invitrogen), and AECBM (from ATCC and PromoCell) Vessel coating: laminin-enriched 804G-conditioned medium | ALI: Pneumacult ALI medium | Cell divisions until P25-P30 (PD > 40) Goblet cell differentiation until P25, but efficient ciliation until P10 Physiological CFTR reactions—until P8 TEER – stable | 1. Expansion possible up to 25 passages (PD 40) 2. Expansion is efficient (from 1–20 *103 cells to ~ 1 × 10 15 cells at P10—in 50 days) 3) BAL or induced sputum samples (< 2000 cells) expanded to 109 or 1010 within 1 month | Resemblance to native epithelium decreases with time (CFTR reactions only until P8, mucociliary differentiation until P10) 3) Culture from induced sputum samples less effective than from BAL |
| OTHER SUPPLEMENTS/ INHIBITORS | Zhang et al. [ | NO | Submerged culture: KSFM with 1 µM A83-01, 5 µM Y-27632, (KSFM + A + Y) Vessel coating: collagen I | ALI, Filter seeding in EpiX + 1.5 mM CaCl2. After confluence, basolaterally Pneumacult-ALI medium | EpiX medium supports efficient HBECs expansion and differentiation until 45–60 PDs (P12–P16) | 1. Increased cell yield (> 50 mln cells from CF patients in 3–4 weeks; > 1 * 106-fold increase) 2. Retained genome integrity, no tumorigenicity 3. Cells have low stress levels 4. Retained CFTR response > 30 PDs (reduced, but exists); 5. Single cell cloning possible | Large cells accumulated slowly over passages and eventually the majority of the population appeared senescent or differentiated | |
| Lu et al. [ | NO | Submerged culture: SAEG with A-8301 (1 μM) and Y27632 (5 μM), rapamycin (5 nM) Vessel coating: N/A | ALI Filter seeding: growth medium, Pneumacult-ALI and DMEM with 4-(2-hydroxyethyl)-1-piperazineethaNesulfonic acid (2:1:1 ratio) 12 h after filter seeding: complete Pneumacult-ALI medium (submerged, ALI from day 1) | Expansion for at least P15 (40–50 PDs) Cells retain BC markers (NGFR, PDPN) Differentiation until P16 | 1. Efficient generation of cultures from neonatal tracheal aspirates 2. Efficiency of mucociliary differentiation comparable to other methods | Abrupt halt of proliferation at the end of the culture– probably due to telomere erosion | ||
| Koh et al. [ | HBE cells, from leftover transplant | NO | Submerged culture: BEGM + 10 uM Y-27632 Vessel coating: human placental collagen | Medium: LHC:DMEM mixture with supplements [ | N/A | Double nucleofection allowed up to 100% targeting without antibiotic selection | ||
Fig. 4Choice of the CRC HAE culturing method depending on the experimental application. CBF – ciliary beat frequency
CRC HAE culture cell yield and success rate depending on the tissue collected
| Sampling method | Age group (condition) | Initial cell number | Subculturing method | Success rate in propagation | References |
|---|---|---|---|---|---|
| Induced sputum | Children | < 2000 cells/ portion | CRC HAE mono (Rho/SMAD inhibition) | 20% in CF patients | Mou et al. [ |
| Tracheal aspirate | Neonatal | < 100 cells/ aspirate | CRC HAE mono (Rho/SMAD/mTOR inhibition) | 40% from single sample, 80% if multiple samples/ patient | Lu et al. [ |
| BAL | Neonatal | < 2000 cells/ portion | CRC HAE, mono (Rho/SMAD inhibition) | 100% (multiple samples/ patient) | Mou et al. [ |
| Nasal brushing | N/A (CF or healthy) | 0.4 to 1.5 million viable cells | Traditional ALI culture | Culture initiation: CF patients—66%; healthy—85% Differentiation in ALI: 100% | Schogler et al. [ |
| Bronchial brushing | N/A | 0.045 – 0.2 mln cells/ brush | Indirect CRC HAE co-culture: HAE cells cultured with conditioned fibroblast medium with ROCKi | N/A | Wolf et al. [ |
| Bronchial brushing (non-bronchoscopic) | Children (healthy or asthmatic) | ~ 2,67 mln cells/ 2 brush passes | CRC HAE co-culture, direct | N/A | Martinovich et al. [ |
BAL Bronchioalveolar lavage, CRC HAE mono conditionally reprogrammed human airway epithelial monoculture (without feeder cells), CRC HAE co-culture conditionally reprogrammed human airway epithelial co-culture (with feeder cells)